Notably, PLWH with a baseline CD4+ T-cell count over 500 cells/μl displayed a higher dyslipidemia prevalence compared with those with lower counts (35.5% vs. 23.3%, QB = 8.0, P = 0.02). This evidence concerns the gene CD4 and metabolic syndrome.